Advisor Group Holdings, Inc. Dyne Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8,660 shares of DYN stock, worth $128,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,660
Previous 46
18726.09%
Holding current value
$128,081
Previous $1,000
31000.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
208Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$119 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$109 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$102 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$101 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$101 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $766M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...